US DoD exercised option for IXIARO vaccine for Japanese encephalitis with Valneva
On Jan. 14, 2020, Valneva announced that the U.S. Department of Defense (DoD) had exercised an option to…
On Jan. 14, 2020, Valneva announced that the U.S. Department of Defense (DoD) had exercised an option to…
On Jan. 14, 2020, Evotec announced that the wholly-owned Seattle based company Just – Evotec Biologics had initiated…
On Jan 31, 2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency…
On Jan. 13, 2020, a new Cleveland Clinic study uncovered a genetic anomaly associated with poor response to…
On Jan. 13, 2020, Vanderbilt University Medical Center researcher Ela Knapik, MD and her colleagues announced they had…
On Jan. 10, 2020, Mayo Clinic researchers reported that they had discovered a molecular switch for repairing central…
On Jan. 9, 2020, Mayo Clinic announced it was creating a library of genomic sequencing data on 100,000…
On Jan. 9, 2020, Penn Medicine announced the birth of Benjamin Thomas Gobrecht: his mother, 33-year-old Jennifer Gobrecht,…
On Jan. 8, 2020, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that world-renowned researcher…
On Jan. 8, 2020, Xencor announced a technology license agreement in which Gilead Sciences will access Xencor’s Xtend…
On Jan. 8, 2020, the U.S. Food and Drug Administration (FDA) approved patient-specific airway stents developed by Cleveland…
On Jan. 7, 2020, the Fred Hutchinson Cancer Research Center announced Dr. Thomas J. Lynch Jr. as the…
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
On Dec. 20, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Daiichi Sankyo’s Enhertu…
On Dec. 20, 2019, Dr. Pedro Rosa-Neto announced the discovery that the protein APOEꜫ4 plays a central role…
On Dec. 18, 2019, the Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy…
On Dec. 18, 2019, Seagen and Astellas Pharma announced the U.S. Food and Drug Administration (FDA) had granted…
On Dec. 17, 2019, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that Gregory Friedman,…
On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…
On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…
On Dec. 11, 2019, Dennis Eggers became the first patient in a new clinical trial to receive a…
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
On Dec. 4. 2019, US-based Nanomix announced that the company had received CE Mark for its S1 Assay…
On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…
On Dec. 2, 2019, the U.S. Food and Drug Administration (FDA) announced it had approved the drug crizanlizumab…
On Nov. 24, 2019, Abu Dhabi Health Services Company, the largest healthcare network in the United Arab Emirates…
On Nov. 20, 2019, University of California San Diego (UCSD) researchers provided new insights into a key pathway…
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its…
On Nov. 20, 2019. Bristol-Myers Squibb announced it had completed its acquisition of Celgene. On Jun. 29, 2015,…
On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of…